Cognitive Behavioral Therapy
Cognitive therapy is a more effective treatment for social anxiety disorder than paroxetine alone and than pill placebo.
Research found that cognitive rehabilitation program could improve self-reported cognitive function through 6 months.
Sleep duration was significantly longer and there was less sleep disruption for pregnant women in the sleep enhancement training group compared with that of women in control groups.
Combined pharmacologic and behavioral treatment approaches are more beneficial than either approach alone for chronic pain conditions.
Compared with men, women diagnosed with AUD have higher rates of premature death due to alcohol abuse.
Some of the strategies to improve memory extinction aim at plasticity pathways in the brain with the use of NMDA receptor-modulating drugs, such as D-cycloserine.
Nicola Davies, PhD, suggests that a great deal of research is still required, but apps are certainly showing great promise as a means of enhancing treatment outcomes when used as an adjunct to therapy and medication.
Dr Nicola Davies explores how diagnostic recognition could facilitate the diagnosis and treatment of this serious condition.
In an email interview with Rheumatology Advisor, Louise Sharpe, PhD, spoke about the practical ramifications of her research for clinicians who treat rheumatoid arthritis.
American College of Physician researchers have released 2 recommendations for treatment of chronic insomnia disorder.
At least 50% of patients who recover from an initial episode of major depressive disorder experience at least 1 subsequent episode.
Cognitive behavioral therapy techniques improve time to resolution of depression in teens who refuse antidepressants.
Psychiatry Advisor Articles
- Treatment-Resistant Depression: Intensive Short-Term Dynamic Psychotherapy Vs Treatment As Usual
- PTSD Symptoms May Be Eased by Non-Invasive Neurotechnology
- Psychosis in Alzheimer's Disease Induced by Female-Specific Gene
- Bipolar Disorder Mobile Apps May Not Address Consumer Needs
- Alzheimer's Drugs See Steep Drop in Adherence